Correlation Between INmune Bio and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both INmune Bio and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on INmune Bio and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and Reviva Pharmaceuticals.
Diversification Opportunities for INmune Bio and Reviva Pharmaceuticals
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between INmune and Reviva is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of INmune Bio i.e., INmune Bio and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between INmune Bio and Reviva Pharmaceuticals
Given the investment horizon of 90 days INmune Bio is expected to under-perform the Reviva Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, INmune Bio is 1.63 times less risky than Reviva Pharmaceuticals. The stock trades about -0.11 of its potential returns per unit of risk. The Reviva Pharmaceuticals Holdings is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 99.00 in Reviva Pharmaceuticals Holdings on August 25, 2024 and sell it today you would earn a total of 15.00 from holding Reviva Pharmaceuticals Holdings or generate 15.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
INmune Bio vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| INmune Bio |
| Reviva Pharmaceuticals |
INmune Bio and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with INmune Bio and Reviva Pharmaceuticals
The main advantage of trading using opposite INmune Bio and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| INmune Bio vs. Eliem Therapeutics | INmune Bio vs. HCW Biologics | INmune Bio vs. RenovoRx | INmune Bio vs. Tempest Therapeutics |
| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |